DBS is not a cure
Stimulation may reduce selected motor symptoms, but the underlying neurological condition continues and medicines or therapy may remain necessary.
Deep brain stimulation cost in Turkey
Deep brain stimulation is a long-term neurological treatment pathway, not a single operating-room charge. A careful Turkey estimate begins with confirming the diagnosis, medication response, cognitive and psychiatric fitness, target selection, imaging, and realistic goals. It then separates lead implantation, pulse-generator placement, device model, anesthesia, hospital stay, programming, medication adjustment, rehabilitation, battery or rechargeable-system service, and home-country follow-up. DBS can reduce selected symptoms for some patients, but it does not cure the underlying disorder and is not suitable for everyone.
How much does deep brain stimulation cost in Turkey?
A standard DBS pathway in Turkey, including specialist assessment, one or two implanted leads, a pulse generator, surgery, hospital care, initial programming, and early review, may be planned at TRY 1,410,000 to 2,820,000, about USD 30,000 to 60,000. A complex bilateral case, advanced rechargeable device, difficult anatomy, longer programming, or revision may reach TRY 2,820,000 to 4,230,000 or more, about USD 60,000 to 90,000+. The device, target, hospital, diagnosis, anesthesia, programming schedule, and future battery plan drive the final cost. Improvement cannot be guaranteed.
USD examples use approximately TRY 47 per USD, close to the official indicative rate checked on 17 July 2026. Device imports and exchange rates can change. Ask whether the quote includes unilateral or bilateral leads, generator, rechargeable or non-rechargeable system, imaging, microelectrode recording, anesthesia, programming, medicines, hotel, taxes, and future replacement.
Share the basics and the Virello team will guide you toward the next step.
Prefer email? Write to support@virellohealth.com.
Reviewed 2026-07-19
Clinical review: Virello Health Clinical Content Team · Editorial review: Virello Health Research Team
Billing context: TRY and USD
Stimulation may reduce selected motor symptoms, but the underlying neurological condition continues and medicines or therapy may remain necessary.
Diagnosis, medication response, cognition, mood, speech, balance, gait, goals, and support determine whether benefits may outweigh risks.
The first settings are not the final settings. Multiple sessions adjust stimulation and medicines while side effects are watched.
Rechargeable life, charging habits, MRI conditions, battery replacement, remote access, and local service affect the long-term plan.
Movement-disorder neurology, functional neurosurgery, neuropsychology, programming, nursing, and rehabilitation must work together.
Cost at a glance
The scenarios separate routine and complex pathways. They are not fixed packages and should be replaced by a report-led hospital estimate before travel.
| Scenario | TRY | USD | Patient and treatment context | Planning scope |
|---|---|---|---|---|
| Standard bilateral DBS pathway | TRY 1,410,000 - 2,820,000 | USD 30,000 - 60,000 | A carefully selected patient with Parkinson disease, essential tremor, or dystonia whose symptoms and medication response support stimulation. | Should include movement-disorder assessment, imaging, lead and generator system, staged or single admission, anesthesia, programming, and early medication review. |
| Advanced rechargeable or complex target pathway | TRY 2,115,000 - 3,525,000 | USD 45,000 - 75,000 | A patient requiring a rechargeable system, complex target, extensive programming, neuropsychology, or additional rehabilitation and travel support. | Confirm device model, charging equipment, programming visits, target rationale, battery life assumptions, and home programming access. |
| Revision or high-complexity care | TRY 2,820,000 - 4,230,000+ | USD 60,000 - 90,000+ | A patient with prior DBS, lead migration, infection, hardware failure, unusual anatomy, uncertain benefit, or a need for revision and staged troubleshooting. | Needs operative records, imaging, device interrogation, infection plan, revision risks, and long-term specialist continuity. |
Usually included
Diagnosis confirmation, medication response, symptom scoring, cognitive and psychiatric review, goals, imaging, and multidisciplinary selection.
A surgical consultation alone is not candidacy testing.
Named lead and generator system, stereotactic planning, anesthesia, lead placement, pulse-generator placement, monitoring, and hospital care.
Unilateral and bilateral scope differs.
Initial device interrogation, programming, side-effect review, medicine adjustment, patient teaching, and early appointments.
Ask how many visits are included.
Programming records, emergency device information, home neurologist link, rehabilitation, battery or charging education, and replacement planning.
Programming cannot be an afterthought.
Confirm separately
Neuropsychology, levodopa challenge, speech and swallowing review, gait assessment, psychiatric care, imaging, and rehabilitation unless listed.
Testing should be clinically tailored.
Charger, patient programmer, replacement controller, battery depletion, generator exchange, remote programming, and international service.
Model first-year and lifetime costs.
Ongoing drugs, physiotherapy, occupational therapy, speech therapy, falls equipment, and caregiver support after the procedure.
DBS does not remove all care.
Bleeding, infection, seizure, stroke, cognitive or psychiatric change, hardware problem, lead revision, or hospital care after returning home.
Ask who manages urgent events.
Candidate context
DBS is considered for selected people with a confirmed movement disorder when symptoms remain disabling despite appropriate medication or when medication side effects are difficult to manage. The team should confirm whether the main problem is Parkinson disease, essential tremor, dystonia, or another condition, and whether the symptoms are likely to respond to stimulation. Cognition, mood, impulse control, speech, swallowing, gait, balance, falls, sleep, frailty, other illness, caregiver support, and ability to attend programming are part of the assessment. A patient should receive an honest discussion of benefits, limits, alternatives, and the possibility that some symptoms will not improve.
DBS targets selected circuits and symptoms. A movement-disorder neurologist should explain which symptom is expected to respond and which is not.
A meaningful response to levodopa in Parkinson disease or severe medication-resistant tremor can support selection, but each case is individualized.
Memory, depression, anxiety, psychosis, impulse control, and decision-making need careful review and treatment.
MRI, blood-thinner review, anesthesia, infection risk, skull and brain anatomy, and ability to manage a programmer or charger matter.
The patient and caregiver need a realistic plan for programming visits, medicines, falls, rehabilitation, travel, and future generator care.
Movement-disorder review may adjust timing, formulation, dosage, rescue therapy, or treatment of a medication side effect before surgery.
Selected tremor or other indications may have a lesioning option, with different eligibility, permanence, side effects, and availability.
Some Parkinson symptoms may be approached with infusion treatment or other advanced therapies after specialist assessment.
Physiotherapy, occupational therapy, speech and swallowing treatment, exercise, falls prevention, and caregiver support remain useful with or without DBS.
Procedure variations
Technique, device, medicine, treatment extent, and prior care can change both the clinical plan and the estimate.
One lead and generator pathway targets symptoms that are meaningfully asymmetric or localized.
The device and programming scope differs from bilateral treatment.
Two leads are planned for symptoms affecting both sides or a broader treatment goal.
The surgical and programming burden is larger.
A rechargeable pulse generator may reduce replacement operations but requires reliable charging and device support.
Confirm charging ability and service access.
Lead, generator, extension, infection, or hardware problems are evaluated before a revision plan.
Prior device records are essential.
City comparison
Only cities with evidence for the procedure should appear here. A city range does not prove that every hospital in that city can manage the same case complexity.
| City | Local range | USD range | Capability context | Stay planning |
|---|---|---|---|---|
| Istanbul | TRY 1,410,000 - 4,230,000+ | USD 30,000 - 90,000+ | Broad functional neurosurgery, movement-disorder, imaging, and programming services. | Verify the target team, device distributor, programming schedule, and intensive-care backup. |
| Ankara | TRY 1,410,000 - 3,760,000+ | USD 30,000 - 80,000+ | University and tertiary hospitals can support complex neurology and neurosurgery assessment. | Confirm neuropsychology, imaging, rehabilitation, and long-term programming. |
| Izmir | TRY 1,410,000 - 3,525,000+ | USD 30,000 - 75,000+ | Selected tertiary centers offer movement-disorder and functional neurosurgery services. | Ask how an international patient receives later settings changes. |
| Antalya | TRY 1,457,000 - 3,525,000+ | USD 31,000 - 75,000+ | Private hospital coordination exists at selected providers. | A holiday destination should not replace a specialist programming plan. |
| Bursa | TRY 1,316,000 - 3,055,000+ | USD 28,000 - 65,000+ | Regional tertiary access for selected routine cases. | Complex target or revision work may require a larger center. |
| Kocaeli and Gebze | TRY 1,363,000 - 3,290,000+ | USD 29,000 - 70,000+ | Marmara access with selected hospital and neuroscience teams. | Plan nearby accommodation for imaging and repeated programming. |
| Adana | TRY 1,269,000 - 2,820,000+ | USD 27,000 - 60,000+ | Regional neurology and neurosurgery services with program-level variation. | Verify movement-disorder and device programming depth. |
| Konya | TRY 1,222,000 - 2,585,000+ | USD 26,000 - 55,000+ | Selected tertiary hospitals may assess and treat suitable cases. | Ask for the home-country programming handover. |
| Kayseri | TRY 1,269,000 - 2,820,000+ | USD 27,000 - 60,000+ | Regional option after complete movement-disorder and neuropsychology assessment. | Keep the stay flexible for early programming. |
| Gaziantep | TRY 1,175,000 - 2,585,000+ | USD 25,000 - 55,000+ | A lower quote requires careful verification of team, device, target, and follow-up. | Do not compare surgery-only offers. |
Estimate variables
Parkinson disease, essential tremor, dystonia, symptom pattern, target, staging, and medication response change the pathway.
The operation is not diagnosis-neutral.
Lead, generator, rechargeable or non-rechargeable battery, programmer, charger, warranty, and service access affect lifetime cost.
Record model and serial details.
Bilateral leads, imaging, stereotactic equipment, microelectrode recording, anesthesia, ICU, anatomy, and revision affect cost.
Confirm what the hospital includes.
Initial settings, repeated visits, remote support, medication adjustment, and rehabilitation may continue for months.
Budget first-year care.
Flights, translator, caregiver, home neurologist, device service, emergency route, and generator replacement affect the full journey.
A device without programming is not treatment.
Medical cost breakdown
History, examination, medication response, symptom scales, goal setting, gait, balance, speech, swallowing, and falls.
Video and a medication diary can help.
Memory, executive function, depression, anxiety, psychosis, impulse control, sleep, and caregiver capacity.
Treatable issues should be addressed.
MRI or CT, target planning, blood tests, medication review, anesthesia assessment, and infection screening.
Blood-thinner changes require medical supervision.
Stereotactic planning, frame or frameless guidance, neurophysiology where used, one or two leads, monitoring, and anesthesia.
Staged and asleep approaches differ.
Pulse generator and extensions, wound closure, device testing, hospital observation, and discharge instructions.
Ask whether generator placement is same-day.
Initial interrogation, programming, side-effect counselling, medication plan, charging or programmer teaching, and early review.
Programming is a clinical service.
Wound checks, headache, seizure or stroke monitoring, infection, cognition, balance, and medication changes.
New weakness, speech change, seizure, or severe headache is urgent.
The team adjusts amplitude, pulse width, frequency, contacts, medicines, tremor, rigidity, dyskinesia, gait, speech, and mood.
Several visits are normal.
Charging, battery depletion, generator exchange, lead or extension review, MRI, falls, therapy, and remote programming continue.
Keep the device card available.
Complete journey budget
Patient and attendant costs should be modeled separately from the medical estimate, with flexible dates and a contingency reserve.
Neurology, neuropsychology, imaging, medication challenge, consent, and target planning may require several appointments.
Do not travel for surgery before selection is complete.
Budget hospital stay, wound review, device teaching, programming, caregiver support, and a flexible return flight.
A caregiver is often valuable.
Arrange movement-disorder neurology, programming records, rehabilitation, medicines, falls plan, and urgent device support.
Confirm a real receiving clinician.
Country access
Visa, donor, fertility, medicine, licensing, and treatment-access requirements can change. Confirm current rules with the relevant authority and treating hospital.
Check the exact Turkish hospital, functional neurosurgeon, movement-disorder neurologist, device team, ICU, and international-health authorization.
Keep lead, generator, extension, model, serial, programming history, MRI conditions, and emergency device instructions.
A quote should state initial and later programming, remote support, home neurologist handover, and future generator replacement.
Cognitive reports, videos, scans, passport data, and caregiver information are sensitive records and require clear consent.
Check Turkish e-Visa information and allow for selection, surgery, programming, wound review, and a possible delay.
Hospital selection
Confirm neurologist, functional neurosurgeon, neuropsychologist, imaging, neurophysiology, nursing, rehabilitation, and programming staff.
A surgery-only team is incomplete.
The team should explain diagnosis, target, expected symptom benefit, side effects, lead approach, generator, and alternatives.
Target choice is individualized.
Ask about ICU, bleeding, stroke, seizure, infection, psychiatric change, hardware issue, and urgent device interrogation.
Know the hospital before travel.
List assessment, imaging, leads, generator, anesthesia, monitoring, hospital, programming, medicines, therapy, hotel, taxes, and device service.
Compare a first-year total.
Receive a full operative report, device card, settings, contacts, charging instructions, MRI conditions, and replacement plan.
Continuity is a safety requirement.
Treating team
Confirms diagnosis, tests medication response, sets symptom goals, manages medicines, and participates in programming.
Plans and performs lead and generator implantation, explains surgical risks, and manages hardware or wound problems.
Assesses cognition and mood, supports decision-making, and coordinates rehabilitation, speech, gait, and daily function.
Interrogates the system, adjusts settings, teaches charging and device use, and provides long-term technical continuity.
Treatment timeline
Send diagnosis, medication diary, response, symptom videos, imaging, cognitive history, falls, mood, and previous operations.
The team confirms target symptoms, medication response, cognition, mood, anatomy, surgical risk, goals, and home support.
One or two leads and the pulse generator are placed in one or more stages, followed by wound and neurological observation.
The device is interrogated and settings are introduced with medication and side-effect instructions. The first setting is not final.
Repeated visits refine stimulation and medicines while assessing tremor, rigidity, dyskinesia, gait, speech, mood, and cognition.
Maintain programming records, device card, charging or battery plan, MRI instructions, rehabilitation, and generator replacement planning.
Risks and edge cases
Intracranial lead surgery can rarely cause hemorrhage, stroke, seizure, neurological deficit, or urgent admission.
Ask about emergency and ICU support.
Mood, impulse control, confusion, depression, anxiety, or psychosis can occur or change after surgery or programming.
Caregiver observation matters.
Stimulation can improve one symptom while causing another setting-related problem that requires adjustment.
Do not stop or change settings without the team.
Wound infection, skin erosion, lead migration, extension failure, or generator problem may need antibiotics or revision.
Record the responsible provider.
DBS may not improve cognition, speech, balance, freezing, pain, or every tremor pattern and the condition continues to evolve.
Set symptom-specific goals.
Missed adjustments, inaccessible charging, language barriers, MRI confusion, or no home neurologist can reduce safety and benefit.
Arrange handover before the operation.
Destination comparison
The most suitable destination depends on the individual case, required team, treatment availability, travel route, legal eligibility, budget, and continuity after returning home.
| Decision factor | India | Turkey | Thailand | How to use this |
|---|---|---|---|---|
| Team depth | Major cities have movement-disorder and functional neurosurgery programs with variable access by region. | Tertiary centers and international hospitals vary in target, device, and programming depth. | Specialist programs may be concentrated in major private hospitals. | Select the multidisciplinary program, not the country label. |
| Programming continuity | Often easier for Indian patients who can attend local specialist visits. | International patients need a named home neurologist and settings handover. | Repeat travel may influence affordability. | Model the first year and battery future. |
| Device and scope | Device systems and hospital charges may be itemized separately. | Packages may bundle hardware while excluding long-term settings or replacement. | Premium hospital pricing may separate device and care. | Compare identical device and programming scope. |
| Travel | Strong South Asian, Gulf, and African access. | Strong European, Gulf, and Central Asian access. | Strong Southeast Asian access. | Travel only where follow-up is feasible. |
Decision guidance
A multidisciplinary movement-disorder program confirms the diagnosis, target, device, surgical plan, programming schedule, and home-country handover.
A provider sells DBS as a cure, promises medication independence, skips cognitive review, cannot name the programming team, or quotes surgery only.
The diagnosis is uncertain, medication response is not documented, mood or cognition is unstable, home support is limited, or records are incomplete.
New weakness, speech change, seizure, severe headache, confusion, fever, wound discharge, sudden worsening, or a device emergency needs immediate care.
Reports for review
Prepare a movement-disorder diagnosis, medication list and response diary, videos of target symptoms, UPDRS or tremor scores when available, imaging, neuropsychology, mood and sleep history, falls, speech and swallowing review, previous operations, device records, and caregiver observations. Ask for a Turkish proposal that states target, lead count, generator, staging, anesthesia, programming, rehabilitation, medicines, home neurologist, MRI rules, and future battery care. Selection records are as important as the surgical quote.
Upload medical reportsDescribe onset, progression, asymmetry, tremor, rigidity, dyskinesia, dystonia, gait, freezing, balance, and falls.
Send names, doses, timing, benefit, wearing-off, dyskinesia, side effects, and a symptom diary or video.
Provide MRI or CT reports and images, prior surgery, stroke, tumor, vascular, or structural findings.
Include speech, swallowing, cognition, mood, sleep, work, daily activities, caregiver needs, and therapy.
List heart, lung, bleeding, infection, immune, seizure, anesthesia, and blood-thinner history.
Send memory, executive, mood, impulse-control, psychosis, anxiety, and decision-making assessments.
Identify the symptoms that matter most and what improvement would change daily life.
Share passport, caregiver, language, hotel, flight flexibility, and ability to attend programming.
Request lead, generator, rechargeable choice, programmer, charger, MRI conditions, battery life, and warranty.
Ask for selection, imaging, surgery, wound review, programming, medication changes, rehabilitation, and home handover.
Discuss bleeding, stroke, seizure, infection, mood, cognition, speech, gait, hardware, and limited benefit.
Read videos, neuropsychology, device data, cancellation, refund, emergency, and complaint terms.
Common questions
A standard pathway may be TRY 1,410,000 to 2,820,000 (USD 30,000 to 60,000), while complex or revision care can reach TRY 2,820,000 to 4,230,000 or more.
No. It can reduce selected symptoms for suitable patients but the underlying condition continues and medicines or therapy may still be needed.
Selected patients with a confirmed movement disorder, meaningful medication response or severe medication-resistant symptoms, acceptable cognition and mood, and practical programming support may be considered.
Ask whether leads, generator, extensions, programmer, charger, rechargeable system, accessories, warranty, and future replacement are included.
Several visits are common during the first months, then periodic review continues. The exact need depends on symptoms, settings, medicines, and local support.
No. Tremor, rigidity, bradykinesia, dyskinesia, or dystonia may respond differently, while cognition, speech, balance, freezing, and other symptoms may persist.
It may reduce generator replacement but requires charging habits, equipment, and service. Device choice should follow clinical and practical needs.
Allow for selection, imaging, surgery, wound review, device teaching, early programming, and possible delay. The hospital should set the safe return window.
MRI conditions depend on the exact device, settings, body area, and facility. Carry the device card and obtain current manufacturer and specialist instructions.
New weakness, speech change, seizure, severe headache, confusion, fever, wound discharge, sudden deterioration, or a device emergency needs immediate assessment.
Review and sources
Ranges distinguish a standard bilateral pathway, an advanced rechargeable or complex-target pathway, and revision or high-complexity care. The working conversion is approximately TRY 47 per USD using the official rate source checked on 17 July 2026. The estimate includes the selection work and first-year programming that are frequently omitted from an operating-room price. Movement-disorder guidance and Turkish Ministry sources inform the clinical, provider, and travel questions. A specialist team must confirm candidacy and issue the final quote.
This page is educational and cannot diagnose a movement disorder, determine DBS candidacy, select a brain target or device, predict improvement, or establish Turkish licensing. A multidisciplinary movement-disorder program should assess benefits, limits, alternatives, cognition, mood, surgery, programming, and home support. New weakness, speech change, seizure, severe headache, confusion, fever, wound discharge, sudden deterioration, or a device emergency needs immediate care.
Parkinson's Foundation · Accessed 2026-07-19
Supports: DBS selection, expectations, surgery, programming, and device context.
Republic of Turkey Ministry of Health · Accessed 2026-07-19
Supports: International provider framework.
Republic of Turkey Ministry of Health · Accessed 2026-07-19
Supports: Provider verification.
Republic of Türkiye e-Visa portal · Accessed 2026-07-19
Supports: Travel planning.
Central Bank of the Republic of Turkey via e-Government Gateway · Accessed 2026-07-19
Supports: TRY and USD conversion context.
International Parkinson and Movement Disorder Society · Accessed 2026-07-19
Supports: Movement-disorder assessment context.
Turkish Medicines and Medical Devices Agency · Accessed 2026-07-19
Supports: Device and regulatory context.
Related planning
Review selection, surgery, programming, alternatives, and risks.
Compare another device-based specialist pathway.
Review another elective Turkey pathway and recovery plan.
Compare a different elective surgical journey.
Review Turkey neurosurgery and oncology planning.
Compare a different Turkey neurosurgical journey.
Compare another country and city framework.
Organize medication, imaging, and neuropsychology records.
Plan caregiver travel, admission, and programming.
Request a device and first-year estimate.
Review current travel documentation.
Arrange home neurology continuity.
Questions about an estimate? Email support@virellohealth.com.